Wedbush Reiterates OP Rating, $23 PT On XNPT

Loading...
Loading...
Wedbush is reiterating its OP rating and $23 PT on shares of XenoPort, Inc.
XNPT
. XenoPort closed Wednesday at $6.38. “Our price target of $23/share is derived from a sum of the parts valuation,” Wedbush writes. “We do not include the potential for ex-U.S. royalties for any products, the $290 million in sale-based milestones for XP-13512, or the remaining pre-commercialization milestones.”
Market News and Data brought to you by Benzinga APIs
Posted In: Analyst RatingsHealth CarePharmaceuticalsWedbushXenoPort
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...